Minerva Neurosciences (NERV) Misses Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($1.09), $0.12 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
• Meta AI researcher Andrew Tulloch departs after Muse launch - Semafor
• Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance